TY - JOUR
T1 - Interplay of sex hormones and long-term right ventricular adaptation in a Dutch PAH-cohort
AU - van Wezenbeek, Jessie
AU - Groeneveldt, Joanne A.
AU - Llucià-Valldeperas, Aida
AU - van der Bruggen, Cathelijne E.
AU - Jansen, Samara M. A.
AU - Smits, A. Josien
AU - Smal, Rowan
AU - van Leeuwen, Joost W.
AU - Remedios, Cris dos
AU - Keogh, Anne
AU - Humbert, Marc
AU - Dorfmüller, Peter
AU - Mercier, Olaf
AU - Guignabert, Christophe
AU - Niessen, Hans W. M.
AU - Handoko, M. Louis
AU - Marcus, J. Tim
AU - Meijboom, Lilian J.
AU - Oosterveer, Frank P. T.
AU - Westerhof, Berend E.
AU - Heijboer, Annemieke C.
AU - Bogaard, Harm Jan
AU - Noordegraaf, Anton Vonk
AU - Goumans, Marie José
AU - de Man, Frances S.
N1 - Funding Information:
This research was financially supported by the Netherlands Organization for Scientific Research: NWO-VICI num. 918.16.610 (J.A. Groeneveldt, B.E. Westerhof and A. Vonk Noordegraaf) and NWO-VIDI num. 917.18.338 (F.S. de Man). The work was also funded by the Dutch Heart Foundation Dekker senior post-doc grant num. 2018T059 (J. van Wezenbeek and F.S. de Man) and Dekker Senior Clinical Scientist 2020T058 (M.L. Handoko), and the Netherlands CardioVascular Research Initiative: CVON-2017-10 DOLPHIN-GENESIS (A. Vonk Noordegraaf, F.S. de Man, H.J. Bogaard and MJ Goumans), and CVON-2018-29 PHAEDRA-IMPACT (A. Llucià-Valldeperas, A. Vonk Noordegraaf, F.S. de Man, H.J. Bogaard and MJ Goumans).
Funding Information:
Dr Dos Remedios is on the Board of Medical Advances Without Animals (MAWA). The Sydney Heart Bank received significant funding from MAWA. Dr Keogh is Trustee of Medical Advances Without Animals. Dr Humbert reports personal fees from Acceleron, grants and personal fees from Actelion, grants and personal fees from Bayer Heathcare, personal fees from GSK, personal fees from Merck, outside the submitted work. Dr Mercier reports personal fees from Merck, personal fees from Astra Zeneca, outside the submitted work. The other authors report no conflicts.
Funding Information:
This research was financially supported by the Netherlands Organization for Scientific Research: NWO-VICI num. 918.16.610 (J.A. Groeneveldt, B.E. Westerhof and A. Vonk Noordegraaf) and NWO-VIDI num. 917.18.338 (F.S. de Man). The work was also funded by the Dutch Heart Foundation Dekker senior post-doc grant num. 2018T059 (J. van Wezenbeek and F.S. de Man) and Dekker Senior Clinical Scientist 2020T058 (M.L. Handoko), and the Netherlands CardioVascular Research Initiative: CVON-2017-10 DOLPHIN-GENESIS (A. Vonk Noordegraaf, F.S. de Man, H.J. Bogaard and MJ Goumans), and CVON-2018-29 PHAEDRA-IMPACT (A. Llucià-Valldeperas, A. Vonk Noordegraaf, F.S. de Man, H.J. Bogaard and MJ Goumans).
Publisher Copyright:
© 2021 The Authors
PY - 2022/4
Y1 - 2022/4
N2 - Background: To investigate the association between altered sex hormone expression and long-term right ventricular (RV) adaptation and progression of right heart failure in a Dutch cohort of Pulmonary Arterial Hypertension (PAH)-patients across a wide range of ages. Methods: In this study we included 279 PAH-patients, of which 169 females and 110 males. From 59 patients and 21 controls we collected plasma samples for sex hormone analysis. Right heart catheterization (RHC) and/or cardiac magnetic resonance (CMR) imaging was performed at baseline. For longitudinal data analysis, we selected patients that underwent a RHC and/or CMR maximally 1.5 years prior to an event (death or transplantation, N = 49). Results: Dehydroepiandrosterone-sulfate (DHEA-S) levels were reduced in male and female PAH-patients compared to controls, whereas androstenedione and testosterone were only reduced in female patients. Interestingly, low DHEA-S and high testosterone levels were correlated to worse RV function in male patients only. Subsequently, we analyzed prognosis and RV adaptation in females stratified by age. Females ≤45years had best prognosis in comparison to females ≥55years and males. No differences in RV function at baseline were observed, despite higher pressure-overload in females ≤45years. Longitudinal data demonstrated a clear distinction in RV adaptation. Although females ≤45years had an event at a later time point, RV function was more impaired at end-stage disease. Conclusions: Sex hormones are differently associated with RV function in male and female PAH-patients. DHEA-S appeared to be lower in male and female PAH-patients. Females ≤45years could persevere pressure-overload for a longer time, but had a more severe RV phenotype at end-stage disease.
AB - Background: To investigate the association between altered sex hormone expression and long-term right ventricular (RV) adaptation and progression of right heart failure in a Dutch cohort of Pulmonary Arterial Hypertension (PAH)-patients across a wide range of ages. Methods: In this study we included 279 PAH-patients, of which 169 females and 110 males. From 59 patients and 21 controls we collected plasma samples for sex hormone analysis. Right heart catheterization (RHC) and/or cardiac magnetic resonance (CMR) imaging was performed at baseline. For longitudinal data analysis, we selected patients that underwent a RHC and/or CMR maximally 1.5 years prior to an event (death or transplantation, N = 49). Results: Dehydroepiandrosterone-sulfate (DHEA-S) levels were reduced in male and female PAH-patients compared to controls, whereas androstenedione and testosterone were only reduced in female patients. Interestingly, low DHEA-S and high testosterone levels were correlated to worse RV function in male patients only. Subsequently, we analyzed prognosis and RV adaptation in females stratified by age. Females ≤45years had best prognosis in comparison to females ≥55years and males. No differences in RV function at baseline were observed, despite higher pressure-overload in females ≤45years. Longitudinal data demonstrated a clear distinction in RV adaptation. Although females ≤45years had an event at a later time point, RV function was more impaired at end-stage disease. Conclusions: Sex hormones are differently associated with RV function in male and female PAH-patients. DHEA-S appeared to be lower in male and female PAH-patients. Females ≤45years could persevere pressure-overload for a longer time, but had a more severe RV phenotype at end-stage disease.
UR - https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85122968247&origin=inward
UR - https://www.ncbi.nlm.nih.gov/pubmed/35039146
U2 - 10.1016/j.healun.2021.11.004
DO - 10.1016/j.healun.2021.11.004
M3 - Article
C2 - 35039146
SN - 1053-2498
VL - 41
SP - 445
EP - 457
JO - Journal of Heart and Lung Transplantation
JF - Journal of Heart and Lung Transplantation
IS - 4
ER -